123 related articles for article (PubMed ID: 7386283)
1. Thromboxane A2 receptor antagonism selectively reverses platelet aggregation.
Le Breton GC; Venton DL
Adv Prostaglandin Thromboxane Res; 1980; 6():497-503. PubMed ID: 7386283
[No Abstract] [Full Text] [Related]
2. Synthesis and platelet aggregation inhibitory activity of 10-oxa and 10-thia prostanoic acid derivatives.
Das J; Vu T
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():788-93. PubMed ID: 2960192
[No Abstract] [Full Text] [Related]
3. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
4. Role of thromboxane A2.
Ambler J; Birch J; Maguire ED; Wallis RB
Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
[No Abstract] [Full Text] [Related]
5. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
[TBL] [Abstract][Full Text] [Related]
6. Preparation and biological evaluation of a potential photoaffinity label for the prostaglandin H2/thromboxane A2 receptor.
Arora SK; Kattelman EJ; Lim CT; Le Breton GC; Venton DL
J Med Chem; 1987 May; 30(5):918-24. PubMed ID: 2952799
[TBL] [Abstract][Full Text] [Related]
7. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
Le Breton GC; Venton DL; Enke SE; Halushka PV
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066
[TBL] [Abstract][Full Text] [Related]
8. 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: a potent inhibitor of the blood platelet cyclo-oxygenase.
Le Breton GC; Hung SC; Ghali NI; Venton DL
Prostaglandins; 1984 Apr; 27(4):543-51. PubMed ID: 6427851
[TBL] [Abstract][Full Text] [Related]
9. [Kinetics of the cellular response: the phenomenon of supercooperativity in platelet aggregation].
Vrzheshch PV; Tatarintsev AV; Ershov DE; Fedorov NA; Zaĭtsev SV; Varfolomeev SD
Dokl Akad Nauk SSSR; 1989; 307(2):477-80. PubMed ID: 2509180
[No Abstract] [Full Text] [Related]
10. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
Altman R; Rouvier J; Weisenberger H
Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet aggregation by novel benzoylpyrrole derivatives.
Kurozumi S; Ohtsu A; Hoshina K; Jimba M; Komoriya K; Naruchi T; Wakabayashi T; Hashimoto Y; Ishimoto S
Adv Prostaglandin Thromboxane Res; 1980; 6():305-7. PubMed ID: 7386272
[No Abstract] [Full Text] [Related]
12. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
Parise LV; Venton DL; Le Breton GC
Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the vascular responses to various prostanoic compounds in the puppy and adult dog.
Fitzpatrick T; Harris R; Ramwell P; Kot P
Adv Prostaglandin Thromboxane Res; 1980; 7():727-9. PubMed ID: 6989200
[No Abstract] [Full Text] [Related]
15. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
Gorman RR
Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
[No Abstract] [Full Text] [Related]
16. Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced platelet aggregation.
Venton DL; Enke SE; Le Breton GC
J Med Chem; 1979 Jul; 22(7):824-30. PubMed ID: 109614
[TBL] [Abstract][Full Text] [Related]
17. [Agonist-induced platelet adhesion: use of the method in patients with myocardial infarction].
Atakha ova LE; Mazurov AV; Katsenovich ER; Repin VS
Biull Eksp Biol Med; 1990 Feb; 109(2):135-7. PubMed ID: 2337644
[TBL] [Abstract][Full Text] [Related]
18. The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
Rybicki JP; Venton DL; Le Breton GC
Biochim Biophys Acta; 1983 Mar; 751(1):66-73. PubMed ID: 6830832
[TBL] [Abstract][Full Text] [Related]
19. The platelet fibrinogen receptor.
Peerschke EI
Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
[No Abstract] [Full Text] [Related]
20. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
Vargaftig BB; Fouque F; Joseph D; Odiot J; Benveniste J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():429-33. PubMed ID: 6221558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
